Announced Mon, 6 Jul · 17:27 IST
Regulation 57(5) intimation - no NCD obligations in Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹28.34
prior close
₹28.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.6+1.6+1.6+0.6-1.2+3.1————
Up moveDown movePending
AI summary
Prism Medico and Pharmacy has confirmed under SEBI LODR Regulation 57(5) that it has not issued any non-convertible securities. As a result, there were no interest, dividend, or principal payment obligations due during the quarter from April 1, 2026 to June 30, 2026. This is a routine quarterly compliance intimation submitted to BSE and MSE.
Likely market impact
No material impact. Routine compliance filing confirming no pending NCD-related payments for the quarter.